Read on Twitter
"The U.S. consumer [is] getting less information about where their drugs are made than where their cereal is made," says journalist @KatherineEban, whose new book investigates unsafe conditions in Chinese and Indian factories that make generic drugs sold in the U.S.
!["The U.S. consumer [is] getting less information about where their drugs are made than where their cereal is made," says journalist @KatherineEban, whose new book investigates unsafe conditions in Chinese and Indian factories that make generic drugs sold in the U.S.](https://pbs.twimg.com/media/D7AqME5WwAAi-7Q.png "\"The U.S. consumer [is] getting less information about where their drugs are made than where their cereal is made,\" says journalist @KatherineEban, whose new book investigates unsafe conditions in Chinese and Indian factories that make generic drugs sold in the U.S.")
"If you decide that you don't want to eat factory-farmed meat, you as a consumer can go into a supermarket and buy organic grass-fed meat," says @KatherineEban. "But if you decide you don't want to buy a foreign-manufactured generic [drug] … the consumer really has no control."
Drug plants "make differing levels of quality for different markets," says @KatherineEban. "Their manufacturing standard can be whatever they can get away with. … If they're sending to other parts of the world [besides the U.S.] they lower their quality."
![Drug plants "make differing levels of quality for different markets," says @KatherineEban. "Their manufacturing standard can be whatever they can get away with. … If they're sending to other parts of the world [besides the U.S.] they lower their quality."](https://pbs.twimg.com/media/D7AsaWJWsAA21So.png "Drug plants \"make differing levels of quality for different markets,\" says @KatherineEban. \"Their manufacturing standard can be whatever they can get away with. … If they're sending to other parts of the world [besides the U.S.] they lower their quality.\"")
In her new book "Bottle of Lies," @KatherineEban exposes a system in which FDA regulators visiting generic drug factories abroad are treated to luxury cars and hotel rooms, day-trips, shopping sprees and other perks. "One of my sources called it 'regulatory tourism,'" she says.
